Form 4: USANA CFO Doug Iekking Sells 5,360 Shares

USANA Health Sciences CFO Doug Iekking sold 5,360 shares of common stock at an average price of $18.7525 per share.

Summary

• CFO Doug Iekking executed a sale of 5,360 shares of USANA Health Sciences (USNA) common stock.
• The transaction occurred on May 27, 2026.
• The shares were sold at a price of $18.7525 per share.
• Following this transaction, the reporting person holds 0 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as Form 4 filings regarding insider sales are routine administrative disclosures.

Positives

• The transaction represents a standard divestment by an executive and does not necessarily reflect a change in company fundamentals.

Negatives

• The sale of 5,360 shares by the Chief Financial Officer may be perceived by some investors as a lack of long-term confidence in the stock price.

Risks

• Insider selling can sometimes create negative sentiment among retail investors.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that executive stock sales are common occurrences for liquidity or tax planning purposes and are frequently executed under pre-planned 10b5-1 trading arrangements.

Comparison to Industry Standards

• Insider sales by C-suite executives are standard practice in the health and wellness sector and do not deviate from typical corporate governance norms.

Stakeholder Impact

• Minimal impact expected on shareholders as this is a routine disclosure of executive equity movement.

Key Dates

Keywords

USNA, USANA Health Sciences, Insider Trading, Form 4, CFO, Stock Sale